Welcome

Please select one of the links below to access information relevant to you.

health care professional Healthcare Professionals*

I am a HCP based in Ireland CONTINUE CONTINUE

patient on apixaban Patients on apixaban

I am a patient based in Ireland who has been prescribed apixaban CONTINUE CONTINUE

public member Members of the public

I am a member of the general public based in Ireland CONTINUE CONTINUE

*This promotional site is only intended for healthcare professionals seeking information on ELIQUIS (apixaban) in Ireland.

Report adverse events (Healthcare Professionals in the Republic of Ireland)

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

Healthcare professionals are asked to report any suspected adverse reactions via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com.

Report side effects (Patients and Public in the Republic of Ireland)

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

By reporting side effects you can help provide more information on the safety of this medicine.

Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com.

All corporate names and logos of BMS and/or of its products are trademarks of Bristol-Myers Squibb Company and are protected by national and international intellectual and industrial property laws. All rights reserved over the content of this website.

Pharmacovigilance Notice: This website has not been designed and must not be used to collect or provide safety information related to Bristol-Myers Squibb products. If your query relates to an adverse event experienced by a patient, please contact the Pharmacovigilance Department on 1 800 749 749 (Ireland only freephone number) or +44 1895 523740 (international number) which is available 24 hours a day, 365 days a year, or contact us by email at medical.information@bms.com.

Your use of this website is subject to the Legal Notice, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations.

432IE1600023-01 / ELI/2015/010/1
Date of approval: February 2016

Welcome

Report adverse events (Healthcare Professionals in the Republic of Ireland)

Report side effects (Patients and Public in the Republic of Ireland)

You are about to leave this website

You are about to leave this Website.